By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > Armour Residential REIT: Weakening Fundamentals May Spark Strong Downtrend, Sell (ARR)
News

Armour Residential REIT: Weakening Fundamentals May Spark Strong Downtrend, Sell (ARR)

News
Last updated: 2023/12/21 at 1:07 AM
By News
Share
9 Min Read
SHARE

Investment Thesis

ARMOUR Residential REIT, Inc. (NYSE:ARR) has been on a downward trajectory, losing over 33% of its share value over the last year and underperforming the market by a margin of about 55%.

Contents
Investment ThesisWeakening Fundamentals: Catalyzing The Downward TrajectoryInvestors In LossesTechnical AnalysisMy Final Thoughts
Price Charts

Seeking Alpha

I anticipate a sharp decline in the company’s shares due to the company’s 40% reduction in dividends. To add to its woes, the company appears to have little to nothing attractive to offer investors, as evidenced by poor EPS, high debt-to-equity ratio, and low dividend coverage ratio. To further compound my bleak outlook for this stock, revisions are trending lower, indicating deteriorating fundamentals and leading me to a bearish stance. I recommend selling this stock before it declines further due to the deteriorating fundamentals, especially the downward revisions to revenues and earnings and the significant dividend cuts.

Weakening Fundamentals: Catalyzing The Downward Trajectory

According to my experience, when a company’s earnings estimates rise, so does its stock’s fair value. A higher fair value than the current market price increases investor interest in purchasing the stock, causing its price to rise and vice versa. Given this context, ARR has earnings and revenue revisions that are trending downward, indicating a downward share price trajectory, in my opinion. To begin with, ARR has 2023 and 2024 consensus estimates of 4.49 and 3.79, representing a YoY growth of -22.63% and -15.44% respectively. In my view, this marks the weakening fundamentals of the stock, which is set to persist until 2024.

EPS revisions

Seeking Alpha

Regarding revenue, the consensus estimates are $151.97million in 2023 and $140.53 million in 2024, representing a YoY growth of -7.53% between 2023 and 2024.

Revenue Revisions

Seeking Alpha

Even though a company’s ability to grow its earnings is probably the best measure of its financial health, if it is unable to increase revenues, not much will happen. A company can hardly hope to increase its earnings over the long run without increasing its revenue, which explains why these two parameters interest me.

To shed light on the company’s current situation concerning these two crucial metrics, $3.6 million in revenues were reported in the MRQ, representing an 85.7% year-over-year change. The same period’s EPS of $1.08 is in comparison to $1.60 from a year ago. Only once in the previous four quarters did the company beat EPS projections. Over the past four quarters, the company has failed to surpass consensus revenue estimates. These trends, in my opinion, indicate deteriorating fundamentals, and I anticipate that these trends will worsen when the company’s interest swaps, which have been providing a sizable income stream for the company, expire. With this background, I believe the weakening fundamentals shall catalyze a downward trajectory now and in 2024, as the above projections show.

Investors In Losses

While the goal of any investment is to get considerable returns on investment, ARR appears not to offer an avenue to actualize that goal. This is evidenced by several poor attributes exhibited by the company. To begin with, ARR has a very low return on equity [ROE]. It has a ROE of -11.07%, which means it does not generate any profit for its shareholders relative to their equity investment. This indicates that it is not creating value for its shareholders or rewarding them adequately for their capital contribution.

ROE

YCharts

Additionally, the company has a negative and declining annualized EPS of -10.25, which means investors are losing money for each share they own. I believe this loss could be majorly due to the impairment charges it incurred from the decline in the value of its RMBS portfolio due to rising interest rates and prepayment risk. This challenge is set to persist, given that interest rates are projected to stay elevated for a long time.

Annualised EPS

YCharts

In addition, the company has a total debt of $11.5 billion. With total assets of $13.9 billion and total liabilities of $12.6 billion, ARR has equity of $1.3 billion. This translates to a very high debt-to-equity ratio of 8.8, which means it relies heavily on borrowed funds to finance its operations and growth. This increases its interest expenses and financial leverage and exposes it to the risk of default or bankruptcy if it cannot meet its debt obligations. For instance, its TTM interest expenses amount to $123.2 million, and with negative profitability, its earnings cannot cover these interest expenses. This implies that the company faces a big risk of defaulting on its debt servicing. Further, with a cash flow from operation of $179.89, it means that its operating cash flows can cover its outstanding debt by about 1.56%, which is a very precarious state in my view. Although I appreciate the company’s high liquidity level, I believe it cannot sustain the company for long because I expect a very high cash burn rate, especially when its interest rate swaps expire.

Lastly, it has poor dividend coverage given that they are distributing more than 100% of its earnings, which means it pays out more dividends than it generates from its earnings. This reduces its financial flexibility and ability to invest in new opportunities or maintain its dividend payments in the future.

Dividend Coverage

Wallstreet

Based on this information, I believe selling ARR is long overdue because investors are in losses, which I expect to magnify as the company’s fundamentals weaken.

Technical Analysis

Based on several indicators, this section will cover the technical analysis of ARR. To begin with, this is the trend. ARR is currently in a downtrend, making lower highs and lower lows since Feb 2020. The stock has broken below its 50-day, 100-day, and 200-day moving averages, which are all sloping downward and acting as resistance levels. The stock also trades below a downward trend line that connects the highs of August, September, and October. The stock may face further downside pressure if it breaks below the support level of $13.68, which is the current lowest low.

MAs

Author Analysis On Market Screener

Moving to momentum, ARR is currently showing a strong momentum as it has been trading in a wide 52-week range between $13.32 and $33.38. The stock’s Relative Strength Index [RSI] is 43.3, which is neither overbought nor oversold. However, the RSI also shows a bearish convergence with the price, as it has made a higher low, while the price has made a lower one. This suggests the bearish trend is still on. The stock’s Moving Average Convergence Divergence [MACD] is at -2.2, a sign of a bearish trajectory. The MACD also shows a crossover with its signal line, indicating an increase in momentum.

RSI and MACD

Author Analysis On Market Screener

Based on the technical analysis, ARR is currently in a downtrend with strong momentum. The stock may face more downside risk if it breaks below the support level of $13.68.

My Final Thoughts

In summary, given ARR’s deteriorating fundamentals and the losses it is causing investors, I think the time is right for those who still own it to sell. Technical analysis indicates that the stock is in a bearish trend with a strong momentum. Given the weakening fundamentals and the recent dividend cuts, I believe a significant downward trajectory is on the horizon due to the selling pressure from investors.

Read the full article here

News December 21, 2023 December 21, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Touchstone Sands Capital Select Growth Fund Q1 2025 Commentary (TSNAX)

By News
News

Central Puerto: Solid Fundamentals And Limited Room For Growth (NYSE:CEPU)

By News
News

McCormick & Company, Incorporated (MKC) Q2 2025 Earnings Call Transcript

By News
News

Moat Index Sees Tech Uptick And Consumer Goods Opportunities

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?